Related Experiment Video
Updated: Jun 28, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
[Hemolytic anemia following mitral valve surgery]
C Pollet1, R Ravan, X Marcaggi
1Unité de réanimation polyvalente, service de médecine interne et de cardiologie, centre hospitalier de Vichy, boulevard Denière, 03200 Vichy, France.
Mitral valvuloplasty can lead to hemolytic anemia, a rare complication of mitral valve repair. Early detection through careful patient follow-up is crucial for timely surgical intervention.
Area of Science:
- Cardiology
- Cardiac Surgery
- Hematology
Background:
- Mitral valvuloplasty is a common surgical procedure for mitral valve disease (MVD).
- Potential complications include restenosis and valvular leakage.
- Hemolytic anemia is a less frequent but significant complication.
Observation:
- Hemolytic anemia after mitral valvuloplasty is rare compared to prosthetic valves.
- The onset of anemia can be delayed, ranging from weeks to years post-procedure.
- Anemia is linked to the velocity of the regurgitation jet, not its volume.
Findings:
- Hemolytic anemia is a known complication of mitral valvuloplasty.
- The velocity of the regurgitation jet is the critical factor, not the degree of regurgitation.
- Delayed presentation of hemolytic anemia is possible.
Implications:
- Careful patient follow-up is essential to identify delayed hemolytic anemia.
- Early identification allows for prompt surgical treatment.
- Understanding the jet velocity mechanism aids in risk assessment and management.
More Related Videos
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests

